omega-n-methylarginine has been researched along with azepexole in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (azepexole) | Trials (azepexole) | Recent Studies (post-2010) (azepexole) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 217 | 7 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbato, E; Fontana, D; Iaccarino, G; Izzo, R; Lembo, G; Trimarco, B; Vecchione, C | 1 |
1 other study(ies) available for omega-n-methylarginine and azepexole
| Article | Year |
|---|---|
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Azepines; Brachial Artery; Drug Interactions; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Infusions, Intra-Arterial; Insulin; Isoproterenol; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Phenylephrine; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Regional Blood Flow; Vasoconstrictor Agents; Vasodilator Agents | 1997 |